[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335436-105":59,"doc-detail-335436-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lncrna-malat1-as-diagnostic-and-prognostic-biomarker-in-colorectal-cancers-a-systematic-review-and-meta-analysis","LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers - A systematic review and meta-analysis","","This systematic review and meta-analysis examined the relationship between long non-coding RNA MALAT1 expression and colorectal cancer (CRC). Using studies identified under PRISMA across databases from inception to September 18, 2023, it evaluated diagnostic accuracy and prognostic value and analyzed associations with pathological features. MALAT1 expression showed significant links with distant metastasis and pooled survival outcomes, and case-control diagnostics produced pooled AUC, sensitivity, and specificity estimates.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lncrna-malat1-as-diagnostic-and-prognostic-biomarker-in-colorectal-cancers-a-systematic-review-and-meta-analysis/335436/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lncrna-malat1-as-diagnostic-and-prognostic-biomarker-in-colorectal-cancers-a-systematic-review-and-meta-analysis/335436.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study evaluate about MALAT1 in colorectal cancer?","Question",{"text":112,"@type":113},"It investigates how MALAT1 expression relates to colorectal cancer, focusing on diagnostic accuracy and prognostic value, as well as links with pathological features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the studies selected for the systematic review?",{"text":117,"@type":113},"The review followed PRISMA guidelines and included studies published up to September 18, 2023, from the databases’ inception.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic and prognostic findings were reported?",{"text":121,"@type":113},"The meta-analysis found MALAT1 expression significantly correlated with distant metastasis and was associated with overall survival and disease-free survival; it also produced pooled diagnostic metrics including AUC, sensitivity, and specificity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335436,1790032662,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","PLOS ONE  \nOPEN ACCESS  \nCitation: Masrour M, Khanmohammadi S, Habibzadeh A, Fallahtafti P (2024) LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and metaanalysis. PLoS ONE 19(10): e0308009 . [https://doi](https://doi). org/10 .1371/journal.pone.0308009  \nEditor: Bashdar Mahmud Hussen, Hawler Medical University, IRAQ  \nReceived: May 17, 2024  \nAccepted: July 16, 2024  \nPublished: October 29, 2024  \nCopyright: © 2024 Masrour et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting Information files.  \nFunding: The author(s) received no specific funding for this work.  \nCompeting interests: The authors have declared that no competing interests exist.  \nRESEARCH ARTICLE  \nLncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis  \nMahdi Masrour1,2☯, Shaghayegh Khanmohammadi2,3,4☯ *, Amirhossein Habibzadeh1‡, Parisa Fallahtafti1,5‡  \n1 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 2 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, 3 Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran, 4 Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran, 5 Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran  \n☯ These authors contributed equally to this work.  \n‡ AH and PF also contributed equally to this work.  \n* [Shaghayegh.khanmohammadi@gmail.com](Shaghayegh.khanmohammadi@gmail.com), [sh-khanmohammadi@student.tums.ac.ir](sh-khanmohammadi@student.tums.ac.ir)  \nAbstract  \nObjective  \nThis study investigated the relationship between the long non-coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) expression and colorectal cancer (CRC) using a thorough systematic review and meta-analysis.  \nMethods  \nUnder the PRISMA guidelines, a systematic review was conducted on studies published from the databases’ inception to September 18, 2023. Prognostic value and diagnostic accuracy were explored. Additionally, the association between levels of MALAT1 expression and pathological features was investigated. The statistical analysis was performed using the “meta” package of R.  \nResults  \nAmong the pathological parameters examined, based on three studies involving 51 cases of metastatic CRC and 135 cases of non-metastatic CRC, a statistically significant correlation was found between the expression level of MALAT1 and distant metastasis, with an OR of 16.0118 (95% CI: 4 .5618–56.2015) . Three studies involving 378 cases reported overall survival and had a pooled HR of 2.3854 (95% CI: 1.3272–4.2875) . Three studies involving 436 cases reported disease-free survival and had a pooled HR of 2.4772 (95% CI: 1.3774– 4.4549) . All prognosis studies utilized tumor tissue samples as specimens to assess the expression level of MALAT1 . Case-to-control diagnostic studies with 126 cases and 126  \ncontrols had a pooled AUC value of 0.6173 (95% CI: 0.5436–0.6909), a pooled sensitivity of 0.675 (95% CI: 0.324–0.900), and a pooled specificity of 0.771 (95% CI: 0 .685–0.839) .  \nConclusions  \nThe expression of MALAT1 in CRC is highly correlated with distant metastasis and has an impact on survival and prognosis. MALAT1 could also be employed as a diagnostic biomarker. More prospective studies should be performed to assess the MALAT1 diagnostic potential in the early stages of CRC.  \nIntroduc","cbCaia4JgECN0q5R","https://ap.wps.com/l/cbCaia4JgECN0q5R","pdf",1583743,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What does the study evaluate about MALAT1 in colorectal cancer?\",\"answer\":\"It investigates how MALAT1 expression relates to colorectal cancer, focusing on diagnostic accuracy and prognostic value, as well as links with pathological features.\"},{\"question\":\"How were the studies selected for the systematic review?\",\"answer\":\"The review followed PRISMA guidelines and included studies published up to September 18, 2023, from the databases’ inception.\"},{\"question\":\"What diagnostic and prognostic findings were reported?\",\"answer\":\"The meta-analysis found MALAT1 expression significantly correlated with distant metastasis and was associated with overall survival and disease-free survival; it also produced pooled diagnostic metrics including AUC, sensitivity, and specificity.\"}]","LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers - A systematic review and meta-analysis | PDF",1790010991]